Skip to main content
Not Found
Digital Seminar

Gastrointestinal Pharmacology Update: Prescribing for Patient Outcome Achievement


Speaker:
Peter Buch, MD, AGAF, FACP
Duration:
2 Hours 03 Minutes
Language:
Presented in EN, subtitles in EN and FR, handouts in EN and FR
Copyright:
Mar 24, 2022
Product Code:
POS078432


Description

Watch double certified Clinical Gastroenterologist Dr Peter Buch, as he provides solutions to your most challenging GI-related challenges in practice.  Focusing on common patient concerns, including H pylori, c difficile, inflammatory bowel disease and chronic constipation, you will take away the latest pharmacologic best practice insights to guide your own prescriptive decisions.

Credit

Program Information

Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.



**

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. 
For other credit inquiries not specified below, please contact info@pesi.com or 800-844-8260 before purchase.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.


Pharmacology Nurse Practitioners

This self-study program offers 120 instructional minutes of pharmacology content which is designed to qualify for 2.0 contact hours toward your pharmacology requirement. 


Nurses, Nurse Practitioners, and Clinical Nurse Specialists - ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 2.0 contact hours. Expires: 03/25/2025.


California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 2.0 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.


Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 2.0 self-study contact hours.

CE Broker


Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 2.0 self-study contact hours. Please email cepesi@pesi.com with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.


Physicians

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. This activity was originally recorded on 03/24/2022. It was last reviewed on 03/15/2022 and is valid until 03/16/2025.

 

Physicians should only claim credit commensurate with the extent of their participation in the activity. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.


Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 2.0 hours for completing this self-study program. This activity was originally recorded on 03/24/2022. It was last reviewed on 03/15/2022 and is valid until 03/16/2025

 

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™.


Other Professions

This self-study activity qualifies for 2.0 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



Handouts

Speaker

Peter Buch, MD, AGAF, FACP's Profile

Peter Buch, MD, AGAF, FACP Related seminars and products


Peter Buch, MD, AGAF, FACP, is a double board-certified clinical gastroenterologist,  leading a team that treats all GI conditions. Dr. Buch sits on editorial boards for numerous professional journals and is a highly sought-after international presenter.

Dr. Buch has a passion for teaching. His style is case-based, practical, very interactive and evidence supported. Dr. Buch’s expertise has been shared with experienced clinicians and advanced-level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.

 

Speaker Disclosures:
Financial: Dr. Peter S. Buch has employment relationships with the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter, MD School of Medicine. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Peter S. Buch serves on the FDA and Patient Care Committees at the American College of Gastroenterology. He serves as an editor of peer-reviewed journals. He is a member of the International Association of Medical Science Educators, the AGA Academy of Educators, the American Gastroenterological Association (AGAF), the American College of Physicians (FACP), the Hartford County Medical Association, the American College of Gastroenterology (FACG), and the Connecticut State Medical Society.

 

Content Disclosure:

Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome, and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.

 

 


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Questions?

Visit our FAQ page at https://www.pesicanada.ca/faq or contact us at https://www.pesicanada.ca/contact-us.


Objectives

  1. Determine the current best medication practices for H pylori.
  2. Select up-to-date approaches to manage chronic constipation.
  3. Analyze the best pharmacological strategies for PPI use.
  4. Explore important updates in clostridium difficile treatment.
  5. Plan to incorporate the newest strategies for successful treatment of Inflammatory Bowel Disease.

Outline

Helicobacter Pylori
  • Testing regimens
  • Clarithromycin resistance and need for quadruple therapy
  • Pill burden and risk of recurrence
  • How to manage refractory H pylori
Proton pump inhibitors (PPIs)
  • Who needs chronic therapy
  • REAL side effects of PPIs
Clostridium Difficile
  • Should we still be using Metronidazole?
  • Vancomycin
  • Fidaxomicin
  • Fecal transplants - the ultimate probiotic
  • Bezlotoxumab
Inflammatory Bowel Disease
  • When to consider 5 ASAs
  • Antibiotics
  • Steroids
  • Antimetabolites
  • Anti TNFs
  • Vedolizumab
  • Ustekinumab
  • Tofacitiniub
  • Biosimilars
Opioid Induced Constipation
  • How to choose among: Osmotic or stimulant laxatives
  • PAMORAS: Naloxegol,Naldemedine, Methylnaltrexone
  • Secretogogues like Lubiprostone
  • Selective 5HT4 agonist like Prucalopride

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physicians Assistants

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesicanada.com.

Please wait ...

Back to Top